Healthcare provider profile · identity verified

Cesar H Trabanco, MD

Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism · PONCE, PR · NPI 1104018654

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Cesar H Trabanco, MD received $193.47 in general payments during 2025 across 3 reported records.

Madrigal Pharmaceuticals accounted for 76.6% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$193.47

3 reported records · 3 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Madrigal Pharmaceuticals	Unresolved — no canonical attribution shown	$148.27	76.6%	1	2025
Abbott Laboratories	Unresolved — no canonical attribution shown	$24.98	12.9%	1	2025
Bayer Healthcare Pharmaceuticals Inc.	Unresolved — no canonical attribution shown	$20.22	10.4%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$173.25	2
Education	$20.22	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
REZDIFFRA Normalized: rezdiffra	Drug	Madrigal Pharmaceuticals	$148.27	1	2025
Source payment records 2025-10-28 · Madrigal Pharmaceuticals · $148.27 · Open Payments source
FREESTYLE LIBRE 3 Normalized: freestyle libre 3	Device	Abbott Laboratories	$24.98	1	2025
Source payment records 2025-01-22 · Abbott Laboratories · $24.98 · Open Payments source
Kerendia Normalized: kerendia	Drug	Bayer Healthcare Pharmaceuticals Inc.	$20.22	1	2025
Source payment records 2025-08-19 · Bayer Healthcare Pharmaceuticals Inc. · $20.22 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Synthroid	Levothyroxine Sodium	5287	894
Atorvastatin Calcium	Atorvastatin Calcium	1648	392
Rosuvastatin Calcium	Rosuvastatin Calcium	1239	301
Simvastatin	Simvastatin	1123	227
Gabapentin	Gabapentin	1107	229
Losartan Potassium	Losartan Potassium	974	231
Metformin Hcl	Metformin Hcl	957	209
Levothyroxine Sodium	Levothyroxine Sodium	740	153
Amlodipine Besylate	Amlodipine Besylate	671	170
Janumet	Sitagliptin Phos/Metformin Hcl	659	115
Glimepiride	Glimepiride	613	123
Metoprolol Succinate	Metoprolol Succinate	554	134
Synjardy	Empagliflozin/Metformin Hcl	519	104
Carvedilol	Carvedilol	462	117
Omeprazole	Omeprazole	447	91
Famotidine	Famotidine	442	112
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	426	107
Pantoprazole Sodium	Pantoprazole Sodium	403	97
Lisinopril	Lisinopril	401	93
Hydrochlorothiazide	Hydrochlorothiazide	360	84
Lantus	Insulin Glargine,hum.Rec.Anlog	358	110
Enalapril Maleate	Enalapril Maleate	351	72
Ezetimibe	Ezetimibe	348	80
Clopidogrel	Clopidogrel Bisulfate	328	83
Levoxyl	Levothyroxine Sodium	287	41
Jardiance	Empagliflozin	268	55
Irbesartan	Irbesartan	258	52
Farxiga	Dapagliflozin Propanediol	241	55
Tradjenta	Linagliptin	241	42
Glipizide	Glipizide	237	44
Alendronate Sodium	Alendronate Sodium	233	58
Humalog	Insulin Lispro	229	59
Candesartan Cilexetil	Candesartan Cilexetil	220	42
Pioglitazone Hcl	Pioglitazone Hcl	219	41
Fenofibrate	Fenofibrate,micronized	216	39
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	215	48
Atenolol	Atenolol	209	49
Ozempic	Semaglutide	206	30
Jentadueto	Linagliptin/Metformin Hcl	204	41
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	186	33
Fenofibrate	Fenofibrate Nanocrystallized	179	33
Tamsulosin Hcl	Tamsulosin Hcl	175	42
Metoprolol Tartrate	Metoprolol Tartrate	172	39
Isosorbide Mononitrate Er	Isosorbide Mononitrate	165	33
Fenofibrate	Fenofibrate	164	41
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	159	45
Pravastatin Sodium	Pravastatin Sodium	157	34
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	153	45
Ramipril	Ramipril	151	35
Allopurinol	Allopurinol	148	33
Janumet Xr	Sitagliptin Phos/Metformin Hcl	146	22
Januvia	Sitagliptin Phosphate	146	29
Cilostazol	Cilostazol	142	30
Montelukast Sodium	Montelukast Sodium	140	32
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	139	30
Humalog Kwikpen U-100	Insulin Lispro	136	36
Repaglinide	Repaglinide	133	32
Lansoprazole	Lansoprazole	129	27
Humalog Mix 75-25	Insulin Lispro Protamin/Lispro	121	25
Raloxifene Hcl	Raloxifene Hcl	119	29
Sulindac	Sulindac	115	26
Esomeprazole Magnesium	Esomeprazole Magnesium	111	23
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	109	26
Furosemide	Furosemide	108	35
Meloxicam	Meloxicam	106	29
Hydralazine Hcl	Hydralazine Hcl	105	31
Calcitriol	Calcitriol	96	21
Duloxetine Hcl	Duloxetine Hcl	93	18
Tresiba Flextouch U-200	Insulin Degludec	90	30
Xigduo Xr	Dapaglifloz Propaned/Metformin	88	16
Novolog Flexpen	Insulin Aspart	87	19
Finasteride	Finasteride	84	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	79	15
Metformin Hcl Er	Metformin Hcl	77	15
Glyxambi	Empagliflozin/Linagliptin	75	16
Donepezil Hcl	Donepezil Hcl	74	22
Eliquis	Apixaban	72	18
Meclizine Hcl	Meclizine Hcl	72	16
Fenofibric Acid	Fenofibric Acid (Choline)	71	11
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	70	25
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	70	18
Doxazosin Mesylate	Doxazosin Mesylate	69	18
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	67	suppressed
Valsartan	Valsartan	62	19
Novolog	Insulin Aspart	58	14
Nabumetone	Nabumetone	57	14
Vitamin D2	Ergocalciferol (Vitamin D2)	57	13
Nifedipine Er	Nifedipine	55	16
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	54	14
Ketoconazole	Ketoconazole	53	28
Indapamide	Indapamide	50	11
Methimazole	Methimazole	50	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	48	19
Latanoprost	Latanoprost	48	12
Levemir	Insulin Detemir	47	16
Novolog Mix 70-30	Insulin Aspart Prot/Insuln Asp	47	suppressed
Trulicity	Dulaglutide	47	11
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	46	suppressed
Cabergoline	Cabergoline	45	14
Metoclopramide Hcl	Metoclopramide Hcl	45	11
Insulin Lispro	Insulin Lispro	43	15
Invokana	Canagliflozin	43	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	43	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	42	suppressed
Ibandronate Sodium	Ibandronate Sodium	42	12
Paroxetine Hcl	Paroxetine Hcl	42	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	40	suppressed
Memantine Hcl	Memantine Hcl	40	11
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	40	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	38	20
Levemir Flexpen	Insulin Detemir	38	suppressed
Pen Needle	Pen Needle, Diabetic	38	15
Oxybutynin Chloride Er	Oxybutynin Chloride	37	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	37	suppressed
Xarelto	Rivaroxaban	37	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	15
Humalog Mix 50-50 Kwikpen	Insulin Lispro Protamin/Lispro	36	suppressed
Propranolol Hcl	Propranolol Hcl	36	suppressed
Spironolactone	Spironolactone	36	suppressed
Novofine 32	Pen Needle, Diabetic	35	11
Unifine Pentips	Pen Needle, Diabetic	35	14
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	33	suppressed
Baclofen	Baclofen	32	suppressed
Trueplus Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	32	11
Pentips Pen Needle	Pen Needle, Diabetic	31	11
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	30	21
Clonazepam	Clonazepam	29	11
Diclofenac Sodium	Diclofenac Sodium	29	suppressed
Folic Acid	Folic Acid	29	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	29	15
Olmesartan Medoxomil	Olmesartan Medoxomil	29	suppressed
Sure Comfort	Syringe-Needle,insulin,0.5 Ml	29	suppressed
Anastrozole	Anastrozole	28	suppressed
Invokamet	Canagliflozin/Metformin Hcl	28	suppressed
Pentoxifylline	Pentoxifylline	28	suppressed
Verapamil Er	Verapamil Hcl	28	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	28	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	27	suppressed
Prednisone	Prednisone	27	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	26	16
Easy Touch	Syringe-Needle,insulin,0.5 Ml	26	suppressed
Sertraline Hcl	Sertraline Hcl	26	12
Warfarin Sodium	Warfarin Sodium	26	suppressed
Digoxin	Digoxin	25	suppressed
Glipizide Er	Glipizide	25	suppressed
Nitroglycerin	Nitroglycerin	25	suppressed
Trueplus Insulin Syringe	Syringe And Needle,insulin,1ml	25	suppressed
Diltiazem Hcl	Diltiazem Hcl	24	suppressed
Humulin R	Insulin Regular, Human	24	suppressed
Hydrocortisone	Hydrocortisone	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	23
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Ultiguard Safepack-Pen Needle	Pen Needle, Diabetic,disp Unit	23	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	22	suppressed
Humulin R U-500	Insulin Regular, Human	22	suppressed
Jentadueto Xr	Linagliptin/Metformin Hcl	22	suppressed
Mounjaro	Tirzepatide	22	suppressed
Risedronate Sodium	Risedronate Sodium	22	suppressed
Repatha Sureclick	Evolocumab	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Sure Comfort	Syringe And Needle,insulin,1ml	21	suppressed
Terazosin Hcl	Terazosin Hcl	21	suppressed
Diclofenac Potassium	Diclofenac Potassium	20	suppressed
Flecainide Acetate	Flecainide Acetate	20	suppressed
Humulin N	Insulin Nph Human Isophane	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	20	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Alprazolam	Alprazolam	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	17	suppressed
Ursodiol	Ursodiol	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	16	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	16	16
Ranolazine Er	Ranolazine	16	suppressed
Verapamil Hcl	Verapamil Hcl	16	suppressed
Brilinta	Ticagrelor	15	suppressed
Trandolapril-Verapamil Er	Trandolapril/Verapamil Hcl	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Trueplus Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	15	suppressed
Vytorin	Ezetimibe/Simvastatin	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	14	suppressed
Levobunolol Hcl	Levobunolol Hcl	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Crestor	Rosuvastatin Calcium	13	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Etodolac	Etodolac	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Sure Comfort	Syring-Needl,disp,insul,0.3 Ml	13	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	12	suppressed
Captopril	Captopril	12	suppressed
Colchicine	Colchicine	12	suppressed
Fosinopril Sodium	Fosinopril Sodium	12	suppressed
Fosinopril-Hydrochlorothiazide	Fosinopril/Hydrochlorothiazide	12	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	12	suppressed
Leflunomide	Leflunomide	12	suppressed
Linzess	Linaclotide	12	suppressed
Rivastigmine	Rivastigmine	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	11	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Humalog Kwikpen U-200	Insulin Lispro	11	suppressed
Letrozole	Letrozole	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Naproxen	Naproxen	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$193.47 · 3 records	Madrigal Pharmaceuticals	FREESTYLE LIBRE 3, Kerendia, REZDIFFRA	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error